BCK Capital Management’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

BCK Capital Management’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-74,268	Closed	-$805K	–	110
2023 Q3	$805K	Buy	+74,268	New	+$797K	0.41%	30

BCK Capital Management's BIOS Position: Q4 2023 in Review

BCK Capital Management sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 74,268 shares — an estimated $805K sold.

BCK Capital Management first reported a position in BIOS in Q3 2023 and held it in 1 quarter. The position peaked at $805K in Q3 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

BCK Capital Management reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
BCK Capital Management sold 74,268 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $805K.
BCK Capital Management first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q3 2023 and held it in 1 quarter.
BCK Capital Management's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $805K in Q3 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on BCK Capital Management's 13F filing for Q4 2023, filed 6 Feb 2024.